GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Marksans Pharma Ltd (NSE:MARKSANS) » Definitions » 5-Year Yield-on-Cost %

Marksans Pharma (NSE:MARKSANS) 5-Year Yield-on-Cost % : 2.16 (As of May. 13, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Marksans Pharma 5-Year Yield-on-Cost %?

Marksans Pharma's yield on cost for the quarter that ended in Dec. 2023 was 2.16.


The historical rank and industry rank for Marksans Pharma's 5-Year Yield-on-Cost % or its related term are showing as below:

NSE:MARKSANS' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.63   Med: 1.67   Max: 5.71
Current: 2.16


During the past 13 years, Marksans Pharma's highest Yield on Cost was 5.71. The lowest was 0.63. And the median was 1.67.


NSE:MARKSANS's 5-Year Yield-on-Cost % is ranked better than
51.39% of 502 companies
in the Drug Manufacturers industry
Industry Median: 2.135 vs NSE:MARKSANS: 2.16

Competitive Comparison of Marksans Pharma's 5-Year Yield-on-Cost %

For the Drug Manufacturers - General subindustry, Marksans Pharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marksans Pharma's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Marksans Pharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Marksans Pharma's 5-Year Yield-on-Cost % falls into.



Marksans Pharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Marksans Pharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Marksans Pharma  (NSE:MARKSANS) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Marksans Pharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Marksans Pharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Marksans Pharma (NSE:MARKSANS) Business Description

Traded in Other Exchanges
Address
Veera Desai Extension Road, 11th Floor, Grandeur, Opposite Gundecha Symphony, Oshiwara, Andheri (West), Mumbai, MH, IND, 400053
Marksans Pharma Ltd is a pharmaceutical company. The company is engaged in the research, manufacturing, and marketing of pharmaceutical formulations. It manufactures analgesics, gastroenterology, anti-diabetic, cardiovascular, pain management, gynecology, gastrointestinal and oncologic drugs as well as antibiotics and antiallergic medications. It has a market presence with the majority of the revenue generated from the United States and North America, followed by Europe and the UK, Australia and New Zealand, India, and the Rest of the World.

Marksans Pharma (NSE:MARKSANS) Headlines

No Headlines